[go: up one dir, main page]

AR084421A1 - Betametasona como agente antibacteriano - Google Patents

Betametasona como agente antibacteriano

Info

Publication number
AR084421A1
AR084421A1 ARP110104796A ARP110104796A AR084421A1 AR 084421 A1 AR084421 A1 AR 084421A1 AR P110104796 A ARP110104796 A AR P110104796A AR P110104796 A ARP110104796 A AR P110104796A AR 084421 A1 AR084421 A1 AR 084421A1
Authority
AR
Argentina
Prior art keywords
antibacterial agent
betametasone
betamethasone
derivatives
salts
Prior art date
Application number
ARP110104796A
Other languages
English (en)
Inventor
Aleardo Koverech
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of AR084421A1 publication Critical patent/AR084421A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Reivindicación 1: Betametasona, o derivados o sus sales, como agente antibacteriano.Reivindicación 3: La betametasona de conformidad con la reivindicación 1, caracterizada porque es para el tratamiento de infecciones bacterianas.
ARP110104796A 2010-12-22 2011-12-20 Betametasona como agente antibacteriano AR084421A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10196431 2010-12-22

Publications (1)

Publication Number Publication Date
AR084421A1 true AR084421A1 (es) 2013-05-15

Family

ID=45065907

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110104796A AR084421A1 (es) 2010-12-22 2011-12-20 Betametasona como agente antibacteriano

Country Status (5)

Country Link
US (1) US20140294922A1 (es)
EP (1) EP2654756A1 (es)
AR (1) AR084421A1 (es)
TW (1) TW201233386A (es)
WO (1) WO2012084446A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140377357A1 (en) * 2013-06-19 2014-12-25 Professional Compounding Centers Of America Poloxamer Based Inhalation Composition
US20220143075A1 (en) * 2017-09-25 2022-05-12 Surface Ophthalmics, Inc. Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753218A (en) * 1996-05-03 1998-05-19 Schering Corporation Method for treating inflammation
AU2003232173A1 (en) * 2002-06-12 2003-12-31 Qsi Pharma A/S Compounds and methods for controlling bacterial virulence
CN101648019A (zh) * 2008-08-13 2010-02-17 北京和润创新医药科技发展有限公司 一种治疗眼科炎症的药物组合物及其用途
CN101664382A (zh) * 2009-09-24 2010-03-10 林广杰 一种复方倍他米松注射液的药物新用途

Also Published As

Publication number Publication date
TW201233386A (en) 2012-08-16
WO2012084446A1 (en) 2012-06-28
EP2654756A1 (en) 2013-10-30
US20140294922A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
PH12016500207A1 (en) Anti-infective compounds
MX373444B (es) Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas.
MX2016009898A (es) Tratamientos para acne resistente.
UY34037A (es) Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias.
MX390762B (es) Composiciones de ciclodextrina alquilada y procesos para preparar y utilizar las mismas
UY34545A (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios.
MX386598B (es) Compuestos antibacterianos.
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
CL2015002658A1 (es) Derivados de 2, 3 - disustituto 1- acil -4 amino - 1,2,3,4 tetrahidroquinilina y su uso como inhibidores de bromodominio
MX364486B (es) Derivados de piridazinona-amidas.
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
ES2898695T8 (es) Derivados de benzoxaborol para el tratamiento de infecciones bacterianas
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2015016319A (es) Terapia de combinacion que comprende oxazolidinona-quinolonas para uso en el tratamiento de infecciones bacterianas.
CL2015003019A1 (es) Derivados biaromáticos antibacterianos
UY34615A (es) Nuevos compuestos útiles para el tratamiento de enfermedades degenerativas e inflamatorias.
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
ECSP14011792A (es) Inhibidores de iap
SG10201900541QA (en) Derivatives of xanthone compounds
PH12016501988A1 (en) Antibacterial compounds
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
CL2017002803A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
BR112015016033A2 (pt) composições e métodos para tratamento de infecções por bactérias

Legal Events

Date Code Title Description
FA Abandonment or withdrawal